Loading clinical trials...
Loading clinical trials...
DEP-ruxolitinib Regimen as a Salvage Therapy for Refractory/Relapsed Hemophagocytic Lymphohistiocytosis
Conditions
Interventions
DEP-Ru
Locations
1
China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
June 1, 2018
Primary Completion Date
June 1, 2018
Completion Date
June 1, 2021
Last Updated
May 30, 2018
NCT03259230
NCT05841342
NCT01998633
NCT05384743
NCT04077905
NCT01818908
Lead Sponsor
Beijing Friendship Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions